Resolvin E1 as a novel agent for the treatment of asthma

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 5, 2009, Pages 513-522

  Hisada, Takeshi ^a   Ishizuka, Tamotsu ^a   Aoki, Haruka ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Bronchial asthma; Docosahexaenoic acid; Eicosapentaenoic acid; Lipid mediator; Protectin; Resolvin

Indexed keywords

CD59 ANTIGEN; ICOSAPENTAENOIC ACID; LIPOXIN; OMEGA 3 FATTY ACID; RESOLVIN E1; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BIOLOGICAL ACTIVITY; DIET; DRUG MECHANISM; HUMAN; INFLAMMATION; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; REPEATED DRUG DOSE; REVIEW;

ADULT; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIGENS, CD59; ASTHMA; CHILD; DIETARY FATS; DRUG EVALUATION, PRECLINICAL; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; LIPOXINS; MICE; RECEPTORS, LEUKOTRIENE B4;

EID: 67649607490     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220902865622     Document Type: Review

References (84)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-362
2. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999;402:B5-11 (Pubitemid 129517082)
3. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-4737 (Pubitemid 28215305)
4. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545 (Pubitemid 29381367)
5. Halonen M, Stern DA, Lohman C, et al. Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. Am J Respir Crit Care Med 1999;160:564-570 (Pubitemid 29380673)
6. Venables KM, Chan-Yeung M. Occupational asthma. Lancet 1997;349:1465-1469 (Pubitemid 27212205)
7. McKeever TM, Britton J. Diet and asthma. Am J Respir Crit Care Med 2004;170:725-729 (Pubitemid 39298985)
8. De Caterina R, Endres S, Kristensen SD, Schmidt EB. N-3 Fatty Acids and Vascular Disease. Verona: Bi & Gi Publishers, 1993
9. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-455 (Pubitemid 29368922)
10. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-1118 (Pubitemid 34984601)
11. Weiss U. Insight: inflammation. Nature 2002;420:845-891
12. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871-1875 (Pubitemid 33101574)
13. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71:343S-8S (Pubitemid 30046139)
14. Serhan CN, Clish CB, Brannon J, et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197-1204 (Pubitemid 30786697)
15. Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025-1037 (Pubitemid 35231761)
16. Aoki H, Hisada T, Ishizuka T, et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008;367:509-515 ·· This paper reports the effect of RvE1 on allergic airway inflammation in a mouse model of asthma.
17. Haworth O, Cernadas M, Yang R, et al. Resolvin E1 regulates interleukin 23, interferon-g and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008;9:873-879 ·· This report demonstrates the detailed mechanisms of actions of RvE1 on resolution of allergic inflammation in a mouse model.
18. Payan DG, Wong MY, Chernov-Rogan T, et al. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 1986;6:402-410 (Pubitemid 17195814)
19. Arm JP, Horton CE, Spur BW, et al. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989;139:1395-1400 (Pubitemid 19155496)
20. Mickleborough TD, Lindley MR, Ionescu AA, et al. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006;129:39-49 (Pubitemid 43265241)
21. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556
22. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998;12:221-234 (Pubitemid 28325681)
23. Barnes PJ. Transcription factors in airway diseases. Lab Invest 2006;86:867-872 (Pubitemid 44268162)
24. Grossman A. Steroid safety: the endocrinologist's view. Int J Clin Pract Suppl 1998;96:33-38
25. Hoffmann P, Mest HJ. What about the effects of dietary lipids on endogenous prostanoid synthesis? A state-of-the-art review. Biomed Biochim 1987;46:639-650
26. Lee T, Hoover R, Williams J, et al. Effect of dietary enrichment with eicosapentaenoic and docasahexanoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Eng J Med 1985;312:1217-1224 (Pubitemid 15009155)
27. Hodge L, Salome CM, Hughes JM, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998;11:361-365 (Pubitemid 28108350)
28. Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000;16:861-865 (Pubitemid 32049372)
29. Okamoto M, Mitsunobu F, Ashida K, et al. Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Intern Med 2000;39:107-111 (Pubitemid 30187233)
30. Emelyanov AF. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002;20:596-600 (Pubitemid 35050151)
31. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-361 ·· An outstanding review (Pubitemid 351595216)
32. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007;21:325-332 · This is the first consensus report, to our knowledge, on the definition and mechanisms of resolution. (Pubitemid 46213480)
33. Serhan CN. Guest edition. Special Issue on Lipoxins and Aspirin-Triggered Lipoxins. Prostaglandins Leukot Essent Fatty Acids 2005;73:139-321
34. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation resolution programmes. Nature 2007;447:869-874 (Pubitemid 46920139)
35. Canny G, Levy O, Furuta GT, et al. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA 2002;99:3902-3907 (Pubitemid 34252203)
36. Campbell EL, Louis NA, Tomassetti SE, et al. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 2007;21:3162-3170 (Pubitemid 47565535)
37. Levy BD, Clish CB, Schmidt B, et al. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol 2001;2:612-619 (Pubitemid 32677628)
38. Hong S, Gronert K, Devchand P, et al. Novel docosatrienes and 17S resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J Biol Chem 2003;278:14677-14687 (Pubitemid 36799790)
39. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007;25:101-137 ·· This is an outstanding review on resolution of inflammation and related lipid mediators. (Pubitemid 46697904)
40. Serhan CN, Yang R, Martinod K, et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009;206:15-23
41. Hunter JA, Finkbeiner WE, Nadel JA, et al. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci USA 1985;82:4633-4637 (Pubitemid 16239617)
42. Serhan CN, Hirsch U, Palmblad J, et al. Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett 1987;217:242-246 (Pubitemid 17086752)
43. Fiore S, Maddox JF, Perez HD, et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med 1994;180:253-260 (Pubitemid 24181074)
44. Bonnans C, Fukunaga K, Levy MA, Levy BD. Lipoxin A4 regulates bronchial epithelial cell responses to acid injury. Am J Pathol 2006;168:1064-1072
45. Levy BD, De Sanctis GT, Devchand PR, et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat Med 2002;8:1018-1023 · In this report effects of LXA4 on airway inflammation are demonstrated. (Pubitemid 35033707)
46. Hayhoe RP, Kamal AM, Solito E, et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006;107:2123-2130 (Pubitemid 43289398)
47. Perretti M, Chiang N, La M, et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 2002;8:1296-1302 (Pubitemid 35373563)
48. Goulding NJ, Godolphin JL, Sampson MB, et al. Hydrocortisone induces lipocortin 1 production by peripheral blood mononuclear cells in vivo in man. Biochem Soc Trans 1990;18:306-307 (Pubitemid 20135978)
49. Gronert K, Martinsson-Niskanen T, Ravasi S, et al. Selectivity of recombinant human leukotriene D4, leukotriene B4, and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses. Am J Pathol 2001;158:3-9 (Pubitemid 32096464)
50. Schaldach CM, Riby J, Bjeldanes LF. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 1999;38:7594-7600 (Pubitemid 129516135)
51. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002;68-69:433-455 (Pubitemid 35247413)
52. Lee TH, Crea AE, Gant V, et al. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990;141:1453-1458
53. Levy BD, Lukacs NW, Berlin AA, et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 2007;21:3877-3884 (Pubitemid 350232345)
54. Christie PE, Spur BW, Lee TH. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992;145:1281-1284
55. Celik GE, Erkekol FO, Misirligil Z, et al. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin Exp Allergy 2007;37:1494-1501 (Pubitemid 47460233)
56. Vachier I, Bonnans C, Chavis C, et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 2005;115:55-60 (Pubitemid 40075421)
57. Levy BD, Bonnans C, Silverman ES, et al. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005;172:824-830 (Pubitemid 41369064)
58. PlanagumÀ A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008;178:574-582
59. Arita M, Bianchini F, Aliberti J, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005;201:713-722 · This paper reports the complete stereochemical structure of RvE1 and its receptor. (Pubitemid 40395117)
60. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003;198:977-985 (Pubitemid 37248614)
61. Cash JL, Hart R, Russ A, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008;205:767-775 (Pubitemid 351549876)
62. Arita M, Ohira T, Sun YP, et al. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007;178:3912-3917 · This paper demonstrates that RvE1 interacts with BLT1 and ChemR23. (Pubitemid 46417661)
63. Toda A, Yokomizo T, Shimizu T. Leukotriene B4 receptors. Prostaglandins Other Lipid Mediat 2002;68-69:575-585 (Pubitemid 35247421)
64. Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003;278:43807-43817 (Pubitemid 37346009)
65. Serhan CN, Gotlinger K, Hong S, et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006;176:1848-1859 (Pubitemid 43134330)
66. Mukherjee PK, Marcheselli VL, Serhan CN, et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004;101:8491-8496 (Pubitemid 38736602)
67. Gronert K, Maheshwari N, Khan N, et al. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 2005;280:15267-15278 (Pubitemid 40562883)
68. Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007;178:496-502 ·· This is the first demonstration, to our knowledge, of actions of PD1 on allergic airway inflammation (Pubitemid 46039663)
69. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004;3:401-416 (Pubitemid 38618123)
70. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1199-1205 (Pubitemid 43045627)
71. Duffield JS, Hong S, Vaidya VS, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006;177:5902-5911 (Pubitemid 44628803)
72. Sun YP, Oh SF, Uddin J, et al. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007;282:9323-9334
73. Maloy KJ. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med 2008;263:584-590 (Pubitemid 351678587)
74. Freedman SD, Blanco PG, Zaman MM, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-569 (Pubitemid 38160786)
75. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252 (Pubitemid 28155090)
76. Steinman RM. Linking innate to adaptive immunity through dendritic cells. Novartis Found Symp 2006;279:101-113
77. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007;37(Suppl 1):S53-60 (Pubitemid 350131268)
78. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007;449:419-426 (Pubitemid 47509552)
79. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukocyte Biol 2007;82:1365-1374 (Pubitemid 350276946)
80. Mahnke K, Johnson TS, Ring S, Enk AH. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 2007;46:159-167 (Pubitemid 46601842)
81. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007;7:610-621 (Pubitemid 47123548)
82. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30 (Pubitemid 46020824)
83. Vassiliou EK, Kesler OM, Tadros JH, Ganea D. Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells. J Immunol 2008;181:4534-4544
84. Gadek JE, Demichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, g-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27:1409-1420 (Pubitemid 29406926)